In glioma patients, CBX3 is dramatically upregulated in tumor tissues and cells, correlated with unfavorable prognosis, and it could regulate the proliferation of glioma U87 cells through CDKNIA (S. Zhao et al., 2019). Here, CBX3 is linked to central nervous system cancer.